Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex

European Journal of Pharmacology

Volumn 528, Issue 1-3, 2005, Pages 95-98

  Nakamura, Shigeo ^a   Ago, Yukio ^a   Itoh, Soichi ^a   Koyama, Yutaka ^a   Baba, Akemichi ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Microdialysis; Serotonin (5 HT) release; Zotepine

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE; MONOAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; SEROTONIN; SEROTONIN 1A ANTAGONIST; ZOTEPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ACTIVITY; DRUG EFFECT; EXTRACELLULAR SPACE; IN VIVO STUDY; INTERMETHOD COMPARISON; LOCAL THERAPY; MALE; MICRODIALYSIS; MONOAMINE RELEASE; NONHUMAN; NORADRENALIN RELEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SYSTEMIC THERAPY;

ANIMALS; ANTIPSYCHOTIC AGENTS; DIBENZOTHIEPINS; DOPAMINE; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; NOREPINEPHRINE; PERFUSION; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN; TIME FACTORS;

EID: 28844448723     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.045     Document Type: Article

References (16)

1. A. Adell, and F. Artigas The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems Neurosci. Biobehav. Rev. 28 2004 415 431
2. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex Neuropharmacology 45 2003 1050 1056
3. Y. Ago, S. Nakamura, A. Baba, and T. Matsuda Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex Neuropsychopharmacology 30 2005 43 51
4. W.W. Fleischhacker, C. Barnas, C.H. Stuppäck, B. Unterweger, C. Miller, and H. Hinterhuber Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial Psychopharmacol. Bull. 25 1989 97 100
5. C. Gundlah, K.F. Martin, D.J. Heal, and S.B. Auerbach In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor J. Pharmacol. Exp. Ther. 283 1997 581 591
6. 1A autoreceptors in the action of selective serotonin reuptake inhibitors Eur. J. Pharmacol. 260 1994 251 255
7. L. Lu, B.T. Hope, J. Dempsey, S.Y. Liu, J.M. Bossert, and Y. Shaham Central amygdala ERK signaling pathway is critical to incubation of cocaine craving Nat. Neurosci. 8 2005 212 219
8. M. Petit, J. Raniwalla, J. Tweed, E. Leutenegger, S. Dollfus, and F. Kelly A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trail Psychopharmacol. Bull. 32 1996 81 87
9. E. Richelson, and T. Souder Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds Life Sci. 68 2000 29 39
10. H.L. Rowley, I.C. Kilpatrick, P.L. Needham, and D.J. Heal Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely moving rats Neuropharmacology 37 1998 937 944
11. H.L. Rowley, P.L. Needham, I.C. Kilpatrick, and D.J. Heal A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo Naunyn-Schmiderberg's Arch. Pharmcol. 361 2000 187 192
12. M. Santiago, and B.H. Westerink The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors Eur. J. Pharmacol. 204 1991 79 85
13. A. Schotte, P.F.M. Janssen, W. Gommeren, W.H.M.L. Luyten, P. Van Gompel, A.S. Lesage, K. De Loore, and J.E. Leysen Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology 124 1996 57 73
14. M. Tatsumi, K. Jansen, R.D. Blakely, and E. Richelson Pharmacological profile of neuroleptics at human monoamine transporters Eur. J. Pharmacol. 368 1999 277 283
15. B.H. Westerink, P. de Boer, M. Santiago, and J.B. De Vries Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neurosci. Lett. 167 1994 109 112
16. 2-adrenoceptors Br. J. Pharmacol. 127 1999 1860 1866